Induction Chemotherapy in the Management of Head and Neck Cancer

被引：11
作者：
Fury, Matthew G. [1 ,2 ]
Shah, Jatin P. [3 ,4 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Head & Neck Med Oncol Serv, Dept Med, New York, NY 10065 USA
[2] Cornell Univ, Dept Med, Weill Med Coll, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Head & Neck Serv, Dept Surg, New York, NY 10065 USA
[4] Cornell Univ, Dept Surg, Weill Med Coll, New York, NY 10021 USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2010年 / 101卷 / 04期
关键词：
squamous cell carcinoma; head and neck cancer; induction chemotherapy; SQUAMOUS-CELL CARCINOMA; COOPERATIVE-ONCOLOGY-GROUP; LOCALLY ADVANCED HEAD; PHASE-II TRIAL; HUMAN-PAPILLOMAVIRUS; RANDOMIZED-TRIAL; CONCOMITANT RADIOCHEMOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; NEOADJUVANT CHEMOTHERAPY; ORGAN PRESERVATION;
D O I：
10.1002/jso.21438
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The strategy of induction chemotherapy prior to planned definitive local therapy for head and neck squamous cell carcinoma has been studied for over 30 years. and appears to have a role in select clinical situations. Here we review landmark studies regarding induction chemotherapy, both in the pre-taxane era and in the current taxane era, and we address some of the unresolved questions regarding the role of induction chemotherapy in head and neck cancer. J. Surg. Oncol. 2010:101:292-298. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码：292 / 298
页数：7
相关论文
共 62 条
[1]   Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer [J].
Adelstein, DJ ;
Li, Y ;
Adams, GL ;
Wagner, H ;
Kish, JA ;
Ensley, JF ;
Schuller, DE ;
Forastiere, AA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :92-98
[2]  
ADELSTEIN DJ, 2009, HEAD NECK
[3]   Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines [J].
Aissat, Nasredine ;
Le Tourneau, Christophe ;
Ghoul, Aida ;
Serova, Maria ;
Bieche, Ivan ;
Lokiec, Francois ;
Raymond, Eric ;
Faivre, Sandrine .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) :305-313
[4]   Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation [J].
Belani, CP ;
Barstis, J ;
Perry, MC ;
La Rocca, RV ;
Nattam, SR ;
Rinaldi, D ;
Clark, R ;
Mills, GM .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2933-2939
[5]   The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation [J].
Beuvink, I ;
Boulay, A ;
Fumagalli, S ;
Zilbermann, F ;
Ruetz, S ;
O'Reilly, T ;
Natt, F ;
Hall, J ;
Lane, HA ;
Thomas, G .
CELL, 2005, 120 (06) :747-759
[6]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[7]  
Bossi P, 2009, J CLIN ONCOL, V27
[8]   Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: Results of Eastern Cooperative Oncology Group study E2399 [J].
Cmelak, Anthony J. ;
Li, Sigui ;
Goldwasser, Meredith A. ;
Murphy, Barbara ;
Cannon, Michael ;
Pinto, Harlan ;
Rosenthal, David I. ;
Gillison, Maura ;
Forastiere, Arlene A. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) :3971-3977
[9]   Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma [J].
Denis, F ;
Garaud, P ;
Bardet, E ;
Alfonsi, M ;
Sire, C ;
Germain, T ;
Bergerot, P ;
Rhein, B ;
Tortochaux, J ;
Calais, G .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :69-76
[10]   Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma [J].
Domenge, C ;
Hill, C ;
Lefebvre, JL ;
De Raucourt, D ;
Rhein, B ;
Wibault, P ;
Marandas, P ;
Coche-Dequeant, B ;
Stromboni-Luboinski, M ;
Sancho-Garnier, H ;
Luboinski, B .
BRITISH JOURNAL OF CANCER, 2000, 83 (12) :1594-1598
1234567